Posted in | News | Materials Analysis

New Generation of Tandem Mass Spectrometer from PerkinElmer

At the 2013 American Society for Mass Spectrometry Conference, PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, introduced the AxION iQT gas chromatography tandem mass spectrometer (GC/MS/MS). The AxION iQT system provides greater quantitative capabilities to that of a triple  quadrupole, while quickly identifying compounds like a quadrupole time-of-flight (Q-TOF) at a rate of up to 500 compounds per second. The new mass spectrometer provides laboratories with easier to use technology, faster results, and more specific, selective data needed to make more accurate decisions faster.

"Global regulatory expansion is driving increased adoption of mass spectrometry as the technology provides greater sample insights for many industries," said Dusty Tenney, president of Environmental Health, PerkinElmer. "We've created a new category of mass spectrometry designed to be faster, smarter, modular and easy to operate and maintain that combines superior quantitative and identification performance into one instrument, making this latest generation of technology both user and budget friendly." The Axion iQT GC/MS/MS solution is intuitive, enabling technicians who are not mass spectrometry trained to run their analyses easily and with confidence. The AxION iQT system is the first MS/MS technology that delivers automated method development tools to users, includes advanced application-centric software and provides easy maintenance due to its smart modular system.
PerkinElmer's AxION(R) iQT GC/MS/MS is the first mass spectrometry platform of its kind that performs both superior quantitation and exact mass identification for complex sample analysis (Photo: Business Wire)

These unique features make the AxION iQT system a one-ofa-kind, easy to use MS/MS instrument that enables analytical labs to deliver highly specific and sensitive MS/MS results, quickly and for virtually any application. The new system can thoroughly characterize and easily quantify compounds for a variety of applications, including the analysis of pesticides in food samples to ensure food safety and authenticity, quantitation of non-derivatized steroids, cholesterol and therapeutic drug monitoring in research applications, analysis of drugs in forensic toxicology, and thorough analysis of chemical compositions.

At the ASMS conference PerkinElmer will also announce a new collaboration with CTC Analytics to provide AxION Sample Manager, a complete sample preparation and analysis solution. The AxION Sample Manager is built around the industryleading CTC PAL technology and can be integrated with the AxION iQT for automated sample preparation with unprecedented precision and repeatability.

To learn more about the AxION iQT system, visit PerkinElmer's booth #111 or hospitality suite at the ASMS conference at the Hilton Minneapolis, Marquette IV-VII or visit the Axion iQT website page.

 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PerkinElmer. (2021, March 09). New Generation of Tandem Mass Spectrometer from PerkinElmer. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=37099.

  • MLA

    PerkinElmer. "New Generation of Tandem Mass Spectrometer from PerkinElmer". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=37099>.

  • Chicago

    PerkinElmer. "New Generation of Tandem Mass Spectrometer from PerkinElmer". AZoM. https://www.azom.com/news.aspx?newsID=37099. (accessed November 21, 2024).

  • Harvard

    PerkinElmer. 2021. New Generation of Tandem Mass Spectrometer from PerkinElmer. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=37099.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.